Zai Lab grants share options and RSUs to employees

Zai Lab Limited has granted share options and restricted share units (RSUs) to its employees under the 2024 Equity Incentive Plan. On November 10, 2025, the company awarded 500 options (in ADSs) to one grantee and 72,100 RSUs (in ADSs) to 78 grantees. The options have an exercise price of $24.5 per ADS, while the RSUs have no purchase price.

Both the options and RSUs will vest 25% on each anniversary of the grant date for the next four years, contingent on continued employment. The closing price of the shares on the grant date was $21.89 per ADS on NASDAQ and HK$17.29 per Share on the Stock Exchange. These grants have no performance targets or clawback mechanisms, which the compensation committee views as market competitive and consistent with company practice.

These grants aim to acknowledge and reward employee contributions, fostering additional incentives to maintain and further promote the group's business success. Following these grants, 79,839,923 shares remain available for future grants under the 2024 Equity Incentive Plan.